| thymocyte apoptotic process | GO:0070242 | 2 | 0.519 | |
| positive regulation of apoptotic process involved in morphogenesis | GO:1902339 | 1 | 0.424 | |
| neuron death in response to oxidative stress | GO:0036475 | 9 | 0.359 | |
| patterning of blood vessels | GO:0001569 | 2 | 0.250 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.227 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.200 | |
| amine metabolic process | GO:0009308 | 44 | 0.186 | |
| cellular component disassembly | GO:0022411 | 92 | 0.176 | |
| regulation of apoptotic process involved in morphogenesis | GO:1902337 | 1 | 0.174 | |
| positive regulation of calcium ion transport into cytosol | GO:0010524 | 20 | 0.158 | |
| post embryonic organ development | GO:0048569 | 1 | 0.155 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.151 | |
| mitochondrial fusion | GO:0008053 | 13 | 0.151 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.150 | |
| oxidation reduction process | GO:0055114 | 396 | 0.148 | |
| liposaccharide metabolic process | GO:1903509 | 27 | 0.145 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 3 | 0.145 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.142 | |
| lipid metabolic process | GO:0006629 | 381 | 0.141 | |
| regulation of transporter activity | GO:0032409 | 82 | 0.141 | |
| regulation of calcium ion transport into cytosol | GO:0010522 | 33 | 0.139 | |
| blood vessel remodeling | GO:0001974 | 2 | 0.138 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.127 | |
| regulation of sequestering of calcium ion | GO:0051282 | 41 | 0.127 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.125 | |
| endomembrane system organization | GO:0010256 | 196 | 0.125 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.121 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.119 | |
| multicellular organismal homeostasis | GO:0048871 | 67 | 0.119 | |
| positive regulation of homeostatic process | GO:0032846 | 47 | 0.118 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.117 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.115 | |
| limbic system development | GO:0021761 | 3 | 0.115 | |
| ion transmembrane transport | GO:0034220 | 338 | 0.114 | |
| regulation of transmembrane transport | GO:0034762 | 139 | 0.111 | |
| regulation of immune response | GO:0050776 | 201 | 0.110 | |
| spermatid differentiation | GO:0048515 | 4 | 0.109 | |
| protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | GO:0001844 | 2 | 0.107 | |
| response to cytokine | GO:0034097 | 232 | 0.106 | |
| ion homeostasis | GO:0050801 | 230 | 0.104 | |
| anatomical structure homeostasis | GO:0060249 | 100 | 0.100 | |
| tissue homeostasis | GO:0001894 | 63 | 0.097 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.096 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 102 | 0.095 | |
| regulation of developmental pigmentation | GO:0048070 | 2 | 0.094 | |
| defense response | GO:0006952 | 315 | 0.093 | |
| cell activation | GO:0001775 | 213 | 0.092 | |
| response to salt stress | GO:0009651 | 3 | 0.092 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.091 | |
| regulation of calcium ion transport | GO:0051924 | 79 | 0.091 | |
| divalent metal ion transport | GO:0070838 | 152 | 0.087 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.087 | |
| negative regulation of endoplasmic reticulum calcium ion concentration | GO:0032471 | 6 | 0.087 | |
| positive regulation of calcium ion transport | GO:0051928 | 51 | 0.087 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 37 | 0.087 | |
| cellular chemical homeostasis | GO:0055082 | 180 | 0.086 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 26 | 0.086 | |
| interspecies interaction between organisms | GO:0044419 | 156 | 0.085 | |
| regulation of cellular ph | GO:0030641 | 17 | 0.081 | |
| peptidyl serine phosphorylation | GO:0018105 | 101 | 0.081 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.081 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.080 | |
| glycolipid metabolic process | GO:0006664 | 27 | 0.079 | |
| organ morphogenesis | GO:0009887 | 147 | 0.079 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.078 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.078 | |
| developmental programmed cell death | GO:0010623 | 3 | 0.077 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.077 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.076 | |
| regulation of cell growth | GO:0001558 | 135 | 0.073 | |
| cellular response to oxidative stress | GO:0034599 | 85 | 0.072 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.072 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.071 | |
| regulation of transmembrane transporter activity | GO:0022898 | 74 | 0.071 | |
| protein ubiquitination | GO:0016567 | 314 | 0.071 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.070 | |
| viral process | GO:0016032 | 146 | 0.070 | |
| hypothalamus development | GO:0021854 | 1 | 0.070 | |
| positive regulation of endoplasmic reticulum unfolded protein response | GO:1900103 | 4 | 0.069 | |
| sequestering of calcium ion | GO:0051208 | 17 | 0.069 | |
| mitochondrion organization | GO:0007005 | 156 | 0.068 | |
| regulation of cytoplasmic transport | GO:1903649 | 149 | 0.068 | |
| multi organism cellular process | GO:0044764 | 156 | 0.065 | |
| immune response activating signal transduction | GO:0002757 | 90 | 0.065 | |
| regulation of metal ion transport | GO:0010959 | 120 | 0.065 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.065 | |
| cytokinesis | GO:0000910 | 96 | 0.065 | |
| sequestering of metal ion | GO:0051238 | 24 | 0.065 | |
| negative regulation of binding | GO:0051100 | 57 | 0.065 | |
| immune response | GO:0006955 | 307 | 0.065 | |
| dna catabolic process | GO:0006308 | 49 | 0.065 | |
| vasculature development | GO:0001944 | 181 | 0.064 | |
| cellular response to abiotic stimulus | GO:0071214 | 117 | 0.063 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 128 | 0.062 | |
| cardiovascular system development | GO:0072358 | 262 | 0.062 | |
| regulation of ion transport | GO:0043269 | 189 | 0.061 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.061 | |
| regulation of release of sequestered calcium ion into cytosol | GO:0051279 | 27 | 0.061 | |
| metal ion homeostasis | GO:0055065 | 169 | 0.060 | |
| positive regulation of cell development | GO:0010720 | 92 | 0.060 | |
| angiogenesis | GO:0001525 | 147 | 0.059 | |
| generation of precursor metabolites and energy | GO:0006091 | 68 | 0.059 | |
| post embryonic development | GO:0009791 | 2 | 0.059 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.058 | |
| regulation of response to oxidative stress | GO:1902882 | 26 | 0.058 | |
| kidney development | GO:0001822 | 53 | 0.057 | |
| tissue remodeling | GO:0048771 | 16 | 0.057 | |
| t cell homeostasis | GO:0043029 | 3 | 0.057 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.056 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.056 | |
| positive regulation of cytoplasmic transport | GO:1903651 | 82 | 0.056 | |
| blood vessel development | GO:0001568 | 172 | 0.056 | |
| cell cycle checkpoint | GO:0000075 | 117 | 0.056 | |
| divalent inorganic cation homeostasis | GO:0072507 | 136 | 0.055 | |
| calcium ion homeostasis | GO:0055074 | 122 | 0.055 | |
| ovulation cycle | GO:0042698 | 9 | 0.055 | |
| positive regulation of ion transport | GO:0043270 | 87 | 0.055 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.054 | |
| response to cocaine | GO:0042220 | 1 | 0.054 | |
| regulation of mononuclear cell proliferation | GO:0032944 | 65 | 0.054 | |
| regulation of binding | GO:0051098 | 111 | 0.054 | |
| immune system development | GO:0002520 | 195 | 0.053 | |
| leukocyte activation | GO:0045321 | 164 | 0.053 | |
| metal ion transport | GO:0030001 | 272 | 0.052 | |
| modification of morphology or physiology of other organism | GO:0035821 | 43 | 0.052 | |
| sphingolipid metabolic process | GO:0006665 | 38 | 0.052 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.051 | |
| male gonad development | GO:0008584 | 23 | 0.051 | |
| cation homeostasis | GO:0055080 | 189 | 0.051 | |
| cell division | GO:0051301 | 168 | 0.051 | |
| positive regulation of immune response | GO:0050778 | 159 | 0.051 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.050 | |
| divalent inorganic cation transport | GO:0072511 | 158 | 0.050 | |
| regulation of homeostatic process | GO:0032844 | 121 | 0.050 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 89 | 0.050 | |
| negative regulation of organelle organization | GO:0010639 | 126 | 0.050 | |
| protein insertion into mitochondrial membrane | GO:0051204 | 3 | 0.049 | |
| single organism membrane organization | GO:0044802 | 268 | 0.049 | |
| apoptotic nuclear changes | GO:0030262 | 13 | 0.049 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.049 | |
| regulation of oxidative stress induced cell death | GO:1903201 | 24 | 0.049 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.049 | |
| establishment of protein localization to plasma membrane | GO:0090002 | 68 | 0.049 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.049 | |
| response to inorganic substance | GO:0010035 | 127 | 0.048 | |
| regulation of ion homeostasis | GO:2000021 | 73 | 0.048 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 156 | 0.048 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.048 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.048 | |
| defense response to virus | GO:0051607 | 71 | 0.048 | |
| mitochondrial fission | GO:0000266 | 14 | 0.048 | |
| leukocyte differentiation | GO:0002521 | 98 | 0.048 | |
| regulation of cell activation | GO:0050865 | 125 | 0.047 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.047 | |
| positive regulation of dna metabolic process | GO:0051054 | 73 | 0.047 | |
| organelle fission | GO:0048285 | 149 | 0.047 | |
| cell death in response to oxidative stress | GO:0036473 | 29 | 0.047 | |
| response to light stimulus | GO:0009416 | 87 | 0.047 | |
| hemopoiesis | GO:0030097 | 180 | 0.046 | |
| protein maturation | GO:0051604 | 233 | 0.045 | |
| maintenance of location | GO:0051235 | 112 | 0.045 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.045 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.045 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.045 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.045 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.044 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.044 | |
| interaction with host | GO:0051701 | 42 | 0.044 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 69 | 0.043 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 82 | 0.043 | |
| circulatory system development | GO:0072359 | 262 | 0.043 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.043 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.042 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.042 | |
| immune effector process | GO:0002252 | 159 | 0.042 | |
| negative regulation of homeostatic process | GO:0032845 | 59 | 0.042 | |
| response to lipid | GO:0033993 | 206 | 0.041 | |
| head development | GO:0060322 | 108 | 0.041 | |
| regulation of oxidative stress induced neuron death | GO:1903203 | 9 | 0.041 | |
| negative regulation of sequestering of calcium ion | GO:0051283 | 41 | 0.041 | |
| regulation of lymphocyte activation | GO:0051249 | 103 | 0.041 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.041 | |
| plasma membrane organization | GO:0007009 | 115 | 0.041 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.040 | |
| positive regulation of leukocyte activation | GO:0002696 | 80 | 0.040 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 89 | 0.040 | |
| protein processing | GO:0016485 | 226 | 0.040 | |
| cellular metal ion homeostasis | GO:0006875 | 146 | 0.040 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.039 | |
| cation transport | GO:0006812 | 331 | 0.039 | |
| lymphocyte proliferation | GO:0046651 | 70 | 0.039 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 85 | 0.039 | |
| b cell activation | GO:0042113 | 33 | 0.039 | |
| mitochondrial outer membrane permeabilization involved in programmed cell death | GO:1902686 | 16 | 0.039 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 0.038 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.038 | |
| response to axon injury | GO:0048678 | 1 | 0.038 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.038 | |
| lymphocyte homeostasis | GO:0002260 | 4 | 0.038 | |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001240 | 16 | 0.038 | |
| cell growth | GO:0016049 | 160 | 0.038 | |
| regulation of lymphocyte proliferation | GO:0050670 | 64 | 0.038 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.037 | |
| protein polyubiquitination | GO:0000209 | 110 | 0.037 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.037 | |
| regulation of leukocyte activation | GO:0002694 | 115 | 0.037 | |
| single organism cellular localization | GO:1902580 | 332 | 0.037 | |
| positive regulation of transport | GO:0051050 | 336 | 0.037 | |
| single organism membrane fusion | GO:0044801 | 37 | 0.037 | |
| cellular ion homeostasis | GO:0006873 | 168 | 0.037 | |
| brain development | GO:0007420 | 97 | 0.037 | |
| positive regulation of mononuclear cell proliferation | GO:0032946 | 47 | 0.036 | |
| positive regulation of cellular response to oxidative stress | GO:1900409 | 7 | 0.036 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.036 | |
| peptidyl serine modification | GO:0018209 | 106 | 0.036 | |
| myeloid cell homeostasis | GO:0002262 | 34 | 0.035 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.035 | |
| positive regulation of cell growth | GO:0030307 | 48 | 0.035 | |
| regulation of endoplasmic reticulum unfolded protein response | GO:1900101 | 5 | 0.035 | |
| fertilization | GO:0009566 | 12 | 0.035 | |
| regulation of protein localization | GO:0032880 | 296 | 0.035 | |
| response to topologically incorrect protein | GO:0035966 | 29 | 0.034 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.034 | |
| response to oxidative stress | GO:0006979 | 121 | 0.034 | |
| positive regulation of release of sequestered calcium ion into cytosol | GO:0051281 | 16 | 0.034 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.034 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 15 | 0.034 | |
| response to virus | GO:0009615 | 126 | 0.034 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.034 | |
| protein localization to membrane | GO:0072657 | 160 | 0.034 | |
| membrane organization | GO:0061024 | 292 | 0.034 | |
| negative regulation of protein binding | GO:0032091 | 35 | 0.033 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.033 | |
| protein oligomerization | GO:0051259 | 173 | 0.033 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.033 | |
| inner mitochondrial membrane organization | GO:0007007 | 8 | 0.033 | |
| female genitalia development | GO:0030540 | 2 | 0.033 | |
| regulation of cell development | GO:0060284 | 161 | 0.033 | |
| response to unfolded protein | GO:0006986 | 24 | 0.033 | |
| response to wounding | GO:0009611 | 168 | 0.033 | |
| female gonad development | GO:0008585 | 10 | 0.033 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.033 | |
| membrane fusion | GO:0061025 | 43 | 0.033 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 85 | 0.032 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.032 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 50 | 0.032 | |
| mononuclear cell proliferation | GO:0032943 | 71 | 0.032 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.032 | |
| zymogen activation | GO:0031638 | 70 | 0.032 | |
| cellular response to radiation | GO:0071478 | 65 | 0.031 | |
| protein localization to organelle | GO:0033365 | 280 | 0.031 | |
| mitochondrial fragmentation involved in apoptotic process | GO:0043653 | 7 | 0.031 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.031 | |
| response to ketone | GO:1901654 | 19 | 0.031 | |
| defense response to other organism | GO:0098542 | 129 | 0.031 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.031 | |
| t cell proliferation | GO:0042098 | 45 | 0.031 | |
| regulation of protein binding | GO:0043393 | 66 | 0.031 | |
| cellular response to unfolded protein | GO:0034620 | 16 | 0.031 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 43 | 0.031 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.031 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 1 | 0.031 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.031 | |
| intracellular protein transport | GO:0006886 | 270 | 0.031 | |
| cellular calcium ion homeostasis | GO:0006874 | 117 | 0.030 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.030 | |
| cellular homeostasis | GO:0019725 | 196 | 0.030 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.030 | |
| positive regulation of lymphocyte activation | GO:0051251 | 73 | 0.030 | |
| regeneration | GO:0031099 | 4 | 0.029 | |
| development of primary male sexual characteristics | GO:0046546 | 23 | 0.029 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 118 | 0.029 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.029 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.029 | |
| cellular response to topologically incorrect protein | GO:0035967 | 19 | 0.029 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 46 | 0.029 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.028 | |
| regulation of mitochondrion organization | GO:0010821 | 54 | 0.028 | |
| sensory organ morphogenesis | GO:0090596 | 21 | 0.028 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.028 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.028 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.027 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.027 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 21 | 0.027 | |
| mitotic cell cycle checkpoint | GO:0007093 | 68 | 0.027 | |
| positive regulation of intracellular transport | GO:0032388 | 104 | 0.027 | |
| positive regulation of endopeptidase activity | GO:0010950 | 84 | 0.027 | |
| regulation of nucleoside metabolic process | GO:0009118 | 209 | 0.027 | |
| response to drug | GO:0042493 | 81 | 0.026 | |
| guanosine containing compound catabolic process | GO:1901069 | 239 | 0.026 | |
| mammary gland morphogenesis | GO:0060443 | 2 | 0.026 | |
| ovarian follicle development | GO:0001541 | 5 | 0.026 | |
| response to metal ion | GO:0010038 | 84 | 0.026 | |
| calcium ion transport | GO:0006816 | 147 | 0.026 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 48 | 0.026 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.026 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.026 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.026 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.026 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.026 | |
| protein localization to plasma membrane | GO:0072659 | 93 | 0.026 | |
| regulation of protein complex assembly | GO:0043254 | 147 | 0.025 | |
| pattern specification process | GO:0007389 | 43 | 0.025 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 20 | 0.025 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.025 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.025 | |
| rhythmic process | GO:0048511 | 31 | 0.025 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.025 | |
| renal system development | GO:0072001 | 63 | 0.025 | |
| lymphocyte activation | GO:0046649 | 133 | 0.025 | |
| dna catabolic process endonucleolytic | GO:0000737 | 37 | 0.025 | |
| neurogenesis | GO:0022008 | 169 | 0.025 | |
| odontogenesis | GO:0042476 | 25 | 0.025 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.025 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:2001267 | 2 | 0.025 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.025 | |
| gtp catabolic process | GO:0006184 | 237 | 0.024 | |
| cellular cation homeostasis | GO:0030003 | 163 | 0.024 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.024 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.024 | |
| cell development | GO:0048468 | 328 | 0.024 | |
| regulation of growth | GO:0040008 | 165 | 0.024 | |
| b cell homeostasis | GO:0001782 | 1 | 0.024 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 119 | 0.024 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.024 | |
| tube morphogenesis | GO:0035239 | 95 | 0.024 | |
| protein catabolic process | GO:0030163 | 325 | 0.024 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.024 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.024 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.024 | |
| fibroblast proliferation | GO:0048144 | 33 | 0.024 | |
| appendage morphogenesis | GO:0035107 | 16 | 0.024 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 45 | 0.024 | |
| modification of morphology or physiology of other organism involved in symbiotic interaction | GO:0051817 | 38 | 0.023 | |
| endoplasmic reticulum unfolded protein response | GO:0030968 | 16 | 0.023 | |
| regulation of response to dna damage stimulus | GO:2001020 | 94 | 0.023 | |
| signal transduction by p53 class mediator | GO:0072331 | 72 | 0.023 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.023 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.023 | |
| female sex differentiation | GO:0046660 | 12 | 0.023 | |
| ovulation cycle process | GO:0022602 | 9 | 0.023 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 186 | 0.023 | |
| negative regulation of signal transduction in absence of ligand | GO:1901099 | 16 | 0.022 | |
| response to hormone | GO:0009725 | 175 | 0.022 | |
| regulation of cellular ph reduction | GO:0032847 | 1 | 0.022 | |
| regulation of apoptotic dna fragmentation | GO:1902510 | 3 | 0.022 | |
| leukocyte apoptotic process | GO:0071887 | 31 | 0.022 | |
| cellular response to uv | GO:0034644 | 32 | 0.022 | |
| morphogenesis of an epithelium | GO:0002009 | 60 | 0.022 | |
| response to alcohol | GO:0097305 | 64 | 0.022 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.022 | |
| response to uv | GO:0009411 | 73 | 0.022 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.022 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.022 | |
| activation of immune response | GO:0002253 | 114 | 0.022 | |
| gtp metabolic process | GO:0046039 | 239 | 0.022 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.021 | |
| positive regulation of cell motility | GO:2000147 | 177 | 0.021 | |
| reproductive process | GO:0022414 | 106 | 0.021 | |
| positive regulation of mitochondrion organization | GO:0010822 | 30 | 0.021 | |
| establishment of protein localization to membrane | GO:0090150 | 121 | 0.021 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 70 | 0.021 | |
| urogenital system development | GO:0001655 | 65 | 0.021 | |
| response to reactive oxygen species | GO:0000302 | 61 | 0.021 | |
| negative regulation of response to dna damage stimulus | GO:2001021 | 33 | 0.020 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 38 | 0.020 | |
| locomotory behavior | GO:0007626 | 1 | 0.020 | |
| female gamete generation | GO:0007292 | 2 | 0.020 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.020 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.020 | |
| cellular response to mechanical stimulus | GO:0071260 | 39 | 0.020 | |
| regulation of organ morphogenesis | GO:2000027 | 24 | 0.020 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:2001269 | 1 | 0.020 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.020 | |
| execution phase of apoptosis | GO:0097194 | 32 | 0.020 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.019 | |
| response to toxic substance | GO:0009636 | 37 | 0.019 | |
| regulation of mitochondrial membrane potential | GO:0051881 | 23 | 0.019 | |
| er nucleus signaling pathway | GO:0006984 | 23 | 0.019 | |
| positive regulation of response to oxidative stress | GO:1902884 | 7 | 0.019 | |
| pigmentation | GO:0043473 | 22 | 0.019 | |
| chemical homeostasis | GO:0048878 | 306 | 0.019 | |
| establishment or maintenance of transmembrane electrochemical gradient | GO:0010248 | 2 | 0.019 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 79 | 0.019 | |
| negative regulation of neuron death | GO:1901215 | 32 | 0.019 | |
| generation of neurons | GO:0048699 | 152 | 0.019 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.019 | |
| regulation of protein homodimerization activity | GO:0043496 | 9 | 0.019 | |
| central nervous system development | GO:0007417 | 123 | 0.019 | |
| regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902108 | 18 | 0.019 | |
| immune response regulating signaling pathway | GO:0002764 | 97 | 0.019 | |
| positive regulation of dna catabolic process | GO:1903626 | 2 | 0.019 | |
| neuron death | GO:0070997 | 65 | 0.019 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.019 | |
| cerebral cortex development | GO:0021987 | 10 | 0.019 | |
| regulation of gtp catabolic process | GO:0033124 | 180 | 0.018 | |
| morphogenesis of a branching epithelium | GO:0061138 | 20 | 0.018 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process by cytochrome c | GO:0008635 | 2 | 0.018 | |
| regulation of protein localization to plasma membrane | GO:1903076 | 40 | 0.018 | |
| positive regulation of peptidase activity | GO:0010952 | 88 | 0.018 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.018 | |
| rho protein signal transduction | GO:0007266 | 26 | 0.018 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.018 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 52 | 0.018 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.018 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 97 | 0.018 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.018 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.018 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.018 | |
| morphogenesis of a branching structure | GO:0001763 | 21 | 0.018 | |
| response to mechanical stimulus | GO:0009612 | 51 | 0.017 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 127 | 0.017 | |
| t cell apoptotic process | GO:0070231 | 12 | 0.017 | |
| epithelial tube morphogenesis | GO:0060562 | 38 | 0.017 | |
| protein homooligomerization | GO:0051260 | 100 | 0.017 | |
| response to other organism | GO:0051707 | 261 | 0.017 | |
| response to radiation | GO:0009314 | 151 | 0.017 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.017 | |
| regulation of membrane potential | GO:0042391 | 95 | 0.017 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.017 | |
| positive regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902110 | 16 | 0.017 | |
| response to gamma radiation | GO:0010332 | 14 | 0.017 | |
| mitochondrial membrane organization | GO:0007006 | 40 | 0.017 | |
| tube development | GO:0035295 | 125 | 0.017 | |
| neuron apoptotic process | GO:0051402 | 39 | 0.017 | |
| behavioral defense response | GO:0002209 | 0 | 0.017 | |
| oogenesis | GO:0048477 | 2 | 0.017 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.017 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.017 | |
| epithelium development | GO:0060429 | 227 | 0.017 | |
| male sex differentiation | GO:0046661 | 25 | 0.017 | |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.017 | |
| thymus development | GO:0048538 | 3 | 0.016 | |
| single organism reproductive process | GO:0044702 | 98 | 0.016 | |
| nervous system development | GO:0007399 | 293 | 0.016 | |
| cellular response to light stimulus | GO:0071482 | 34 | 0.016 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.016 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.016 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 185 | 0.016 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.016 | |
| cellular component disassembly involved in execution phase of apoptosis | GO:0006921 | 13 | 0.016 | |
| intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | GO:0070059 | 12 | 0.016 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 57 | 0.016 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.016 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.016 | |
| cellular monovalent inorganic cation homeostasis | GO:0030004 | 26 | 0.016 | |
| growth | GO:0040007 | 202 | 0.015 | |
| positive regulation of gtp catabolic process | GO:0033126 | 166 | 0.015 | |
| regulation of ph | GO:0006885 | 20 | 0.015 | |
| transmembrane transport | GO:0055085 | 399 | 0.015 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 23 | 0.015 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 19 | 0.015 | |
| necrotic cell death | GO:0070265 | 21 | 0.015 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 42 | 0.015 | |
| programmed necrotic cell death | GO:0097300 | 18 | 0.015 | |
| regulation of fibroblast proliferation | GO:0048145 | 32 | 0.015 | |
| biological adhesion | GO:0022610 | 331 | 0.015 | |
| mammary gland involution | GO:0060056 | 1 | 0.015 | |
| regulation of protein heterodimerization activity | GO:0043497 | 5 | 0.015 | |
| cell projection organization | GO:0030030 | 252 | 0.015 | |
| regulation of mapk cascade | GO:0043408 | 262 | 0.015 | |
| positive regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902177 | 4 | 0.014 | |
| limb development | GO:0060173 | 23 | 0.014 | |
| eye development | GO:0001654 | 42 | 0.014 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.014 | |
| response to endoplasmic reticulum stress | GO:0034976 | 49 | 0.014 | |
| spermatid development | GO:0007286 | 4 | 0.014 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.014 | |
| organelle fusion | GO:0048284 | 36 | 0.014 | |
| development of primary female sexual characteristics | GO:0046545 | 10 | 0.014 | |
| hindbrain development | GO:0030902 | 3 | 0.014 | |
| signal transduction in absence of ligand | GO:0038034 | 22 | 0.014 | |
| response to nicotine | GO:0035094 | 12 | 0.014 | |
| mitochondrion morphogenesis | GO:0070584 | 8 | 0.014 | |
| telencephalon development | GO:0021537 | 17 | 0.014 | |
| ph reduction | GO:0045851 | 11 | 0.014 | |
| negative regulation of establishment of protein localization to plasma membrane | GO:0090005 | 9 | 0.014 | |
| response to steroid hormone | GO:0048545 | 80 | 0.013 | |
| positive regulation of developmental pigmentation | GO:0048087 | 2 | 0.013 | |
| transformed cell apoptotic process | GO:0006927 | 3 | 0.013 | |
| cellular protein complex assembly | GO:0043623 | 188 | 0.013 | |
| response to transition metal nanoparticle | GO:1990267 | 29 | 0.013 | |
| regulation of neuron death | GO:1901214 | 56 | 0.013 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.013 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.013 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.013 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 37 | 0.013 | |
| regulation of protein transport | GO:0051223 | 213 | 0.013 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.013 | |
| negative regulation of protein localization to plasma membrane | GO:1903077 | 13 | 0.013 | |
